Health care

• Online Patient-Provider Cannabis Consultations (30 Sep 2024)
  
• An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK? (27 Sep 2024)
  
• Cannabinoids in the Older Person: A Literature Review (26 Sep 2024)
  
• The Void in Clinician Counseling of Cannabis Use (24 Sep 2024)
  
• Cannabis use in pregnancy and breastfeeding: The pharmacist’s role (24 Sep 2024)
  
• A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors (24 Sep 2024)
  
• The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials (16 Sep 2024)
  
• Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists’ knowledge in Bulgaria (16 Sep 2024)
  
• Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use? (16 Sep 2024)
  
• Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers (16 Sep 2024)
  
• Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients (16 Sep 2024)
  
• Commercial Cannabidiol Caution: A New Gold Rush (16 Sep 2024)
  
• Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective (16 Sep 2024)
  
• Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea (16 Sep 2024)
  
• Can prescribed medical cannabis use reduce the use of other more harmful drugs? (16 Sep 2024)
  
• Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database (16 Sep 2024)
  
• A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults (16 Sep 2024)
  
• The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products (03 Sep 2024)
  
• Lessons for cannabinoid regulation from electronic nicotine delivery system product regulation (03 Sep 2024)
  
• Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial (03 Sep 2024)
  
• Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis (02 Sep 2024)
  
• Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England (02 Sep 2024)
  
• The impact of recreational cannabinoid legalization on utilization in a pregnant population (02 Sep 2024)
  
• Patients’ perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients (02 Sep 2024)
  
• Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology (02 Sep 2024)
  
• Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM (02 Sep 2024)
  
• Cannabinoid Awareness, Reporting Use to Health Care Providers, and Perceptions Regarding Safety – Pennsylvania, March 2023–April 2023 (02 Sep 2024)
  
• An answered call for aid? Cannabinoid clinical framework for the opioid epidemic (02 Sep 2024)
  
• cancer pain: an analysis of pain mechanism and cannabinoid profile (30 Aug 2024)
  
• Mediators of Placebo Response to Cannabinoid Treatment in Children with Autism Spectrum Disorder (29 Aug 2024)
  
• Influence of Cannabinoid Treatment on Trajectories of Patient-Related Outcomes in Chronic Pain: Pain Intensity, Emotional Distress, Tolerability and Physical Disability (29 Aug 2024)
  
• Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders (29 Aug 2024)
  
• Cannabis and cannabinoid medications for the treatment of chronic orofacial pain: A scoping review (29 Aug 2024)
  
• Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents (28 Aug 2024)
  
• CANNabinoid Drug Interaction Review (CANN-DIR™) (28 Aug 2024)
  
• Patient-Related Barriers to the Prescription of Cannabinoid-Based Medicines in Palliative Care: A Qualitative Approach (27 Aug 2024)
  
• Safety Considerations in Cannabinoid-Based Medicine (20 Aug 2024)
  
• Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report (20 Aug 2024)
  
• Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis (24 May 2024)
  
• Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a rando (24 May 2024)
  
• Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain (13 May 2024)
  
• A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation (13 May 2024)
  
• A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery (07 Aug 2022)
  
• Comparison of nabiximols versus oral dronabinol for pain (05 Aug 2022)
  
• Medical cannabis in treating patients with sleep disorders (31 Jul 2022)
  
• Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report - Journal of Medical Case Reports (31 Jul 2022)
  
• A critical review of cannabis in medicine and dentistry: A look back and the path forward (31 Jul 2022)
  
• What are the informational pathways that shape people’s use of cannabidiol for medical purposes? - Journal of Cannabis Research (26 Jul 2022)
  
• The therapeutic role of Cannabidiol in mental health: a systematic review - Journal of Cannabis Research (26 Jul 2022)
  
• Staff awareness of the use of cannabidiol (CBD): a trust-wide survey study in the UK - Journal of Cannabis Research (26 Jul 2022)
  
• Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations - Journal of Cannabis Research (26 Jul 2022)
  
• Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists - Journal of Cannabis Research (26 Jul 2022)
  
• Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series - Journal of Cannabis Research (26 Jul 2022)
  
• Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic - Journal of Cannabis Research (26 Jul 2022)
  
• A content analysis of internet information sources on medical cannabis - Journal of Cannabis Research (26 Jul 2022)
  
• Study reveals antibiotic potential of cannabis compound (25 Jul 2022)
  
• Exploring cannabinoid bioavailability in the medical cannabis industry (25 Jul 2022)
  
• Bod Australia to start long Covid-19 trial using medicinal cannabis in UK (25 Jul 2022)
  
• Medical Uses of CBD (21 Jul 2022)
  
• CBD User's Guide (21 Jul 2022)
  
• CBD Dentistry (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Patient Version (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Health Professional Version (21 Jul 2022)
  
• Cannabis and Cancer Part 2: Scientists Look for Ways to Increase Knowledge About Cannabis with Help from People with Cancer (21 Jul 2022)
  
• Cannabis and Cancer, Part 1: Despite Lack of Evidence, Cannabis Products Being Widely Used (21 Jul 2022)
  
• A mixed methods analysis of cannabis use routines for chronic pain management - Journal of Cannabis Research (21 Jul 2022)
  
• What is CBD? Definition of Cannabidiol & CBD Oil (20 Jul 2022)
  
• Single Compound vs. Whole Plant CBD (20 Jul 2022)
  
• CBIS Cannabinoid Research (20 Jul 2022)
  
• Cannabis Therapy for Seizures in Animals (20 Jul 2022)
  
• What Is HHC? (18 Jul 2022)
  
• What is Cannabichromene (CBC)? Benefits, Uses, Dosages (18 Jul 2022)
  
• Very high doses of CBD, a cannabis component, don’t affect driving (18 Jul 2022)
  
• The Science Behind CBD's Effects on the Brain and Body (18 Jul 2022)
  
• Tablet containing CBD shows promise in reducing post-operative pain (18 Jul 2022)
  
• Substance analogous to cannabidiol can enhance chemotherapy by preventing neuropathic pain (18 Jul 2022)
  
• Study provides insights on the effects of cannabidiol on severe form of epilepsy (18 Jul 2022)
  
• Some cannabis products associated with short-term chronic pain improvements, but side effects a concern (18 Jul 2022)
  
• Prescribed CBD could help people quit cannabis (18 Jul 2022)
  
• Pioneering clinical trial to treat psychosis in Parkinson's patients using cannabidiol (18 Jul 2022)
  
• New study: Cannabis helps fight resistant bacteria (18 Jul 2022)
  
• Medicinal cannabis may reduce behavioral problems in kids with intellectual disabilities (18 Jul 2022)
  
• Here’s the truth about CBD, from a cannabis researcher (18 Jul 2022)
  
• Epileptic seizure frequency fell by 86% in kids treated with whole plant medicinal cannabis (18 Jul 2022)
  
• Daily use of cannabidiol (‘CBD’) oil may be linked to lung cancer regression (18 Jul 2022)
  
• Certain CBD oils no better than pure CBD at inhibiting certain cancer cell lines (18 Jul 2022)
  
• CBD shows promise for fighting aggressive brain cancer (18 Jul 2022)
  
• CBD reduces craving and anxiety in people with heroin use disorder (18 Jul 2022)
  
• CBD and THC are Safe Supplements to Opioid Treatment (18 Jul 2022)
  
• Cannabis extract helps reset brain function in psychosis (18 Jul 2022)
  
• Cannabidiol (CBD) in cannabis does not impair driving, landmark study shows (18 Jul 2022)
  
• Animal study shows safety of using CBD and THC with opioids (18 Jul 2022)